Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | GPR88 | Q9GZN0 | 7/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | METAP2 | P50579 | 2/20 | 0.49 |
| ▸ | METAP1 | P53582 | 2/20 | 0.49 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.49 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.49 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.49 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.49 |
| ▸ | PAK4 | O96013 | 1/20 | 0.49 |
| ▸ | PRKCG | P05129 | 1/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.49 |
| ▸ | PRKACA | P17612 | 1/20 | 0.49 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.49 |
| ▸ | CDK2 | P24941 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14224547 | 1.00 | RIPK1 (0.62) | RIPK1LMNAPOLBALDH1A1GPR88 | |
| SCHEMBL14701528 | 0.87 | ALDH1A1 (0.59) | LMNAPOLBALDH1A1EPHX2SMN1; SMN2 | |
| SCHEMBL14535420 | 0.87 | ALDH1A1 (0.59) | LMNAPOLBALDH1A1EPHX2SMN1; SMN2 | |
| SCHEMBL4337456 | 0.87 | RIPK1 (0.58) | RIPK1LMNAALDH1A1GPR88EPHX2 | |
| SCHEMBL16901651 | 0.86 | ROCK1 (0.51) | RIPK1LMNAPOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL6857593 | 0.86 | SMN1; SMN2 (0.64) | LMNAPOLBALDH1A1SMN1; SMN2HTT | |
| SCHEMBL18832653 | 0.84 | RIPK1 (0.55) | RIPK1LMNAALDH1A1GPR88EPHX2 | |
| SCHEMBL14224780 | 0.83 | KMT2A (0.47) | RIPK1LMNAALDH1A1SMN1; SMN2HTT | |
| SCHEMBL686783 | 0.83 | SMN1; SMN2 (0.54) | RIPK1LMNAPOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL31037004 | 0.83 | SLC6A9 (0.47) | RIPK1LMNAALDH1A1SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348369-A1 | NAMPT MODULATORS | CYTOKINETICS, INC. | 2023-11-02 | — | — | US | disclosed |
| US-7354919-B2 | Isoxazole compositions useful as inhibitors of ERK | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348369-A1 | NAMPT MODULATORS | NAMPT, NNT, NAPRT | RIPK1 4224/4885LMNA 1650/4885POLB 4018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.